Scynexis (SCYX) Share-based Compensation (2013 - 2026)
Scynexis (SCYX) reported Share-based Compensation of $580000.0 for Q1 2026, down 29.18% on a YoY basis from $819000.0 in Q1 2025, and down 17.14% quarter-over-quarter from $700000.0 in Q4 2025.
Scynexis (SCYX) Share-based Compensation (2013 - 2026) Analysis & Trends
Scynexis has reported Share-based Compensation for 14 years, with the latest figure at $580000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 29.18% year-over-year to $580000.0; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (down 23.84% YoY), and the FY2025 full-year result was $2.9 million, down 12.12% from the prior year.
- Share-based Compensation for Q1 2026 stood at $580000.0, down from $700000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $1.1 million in Q2 2022, with the low at $453000.0 in Q4 2022.
- Historically, Share-based Compensation has averaged $753117.6 across 5 years, with a median of $707000.0 in 2023.
- Annual changes were most pronounced in 2022 — Share-based Compensation surged 130.5% — and 2025, when it tumbled 44.51%.
- Scynexis' Share-based Compensation stood at $453000.0 in 2022, then grew by 17.66% to $533000.0 in 2023, then surged by 75.42% to $935000.0 in 2024, then declined by 25.13% to $700000.0 in 2025, then dropped by 17.14% to $580000.0 in 2026.
- The last three Share-based Compensation figures came in at $580000.0 (Q1 2026), $700000.0 (Q4 2025), and $500000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | 580,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 580,000.00 |
| Mar 31, 2026 | 580,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 820,000.00 |
| Jun 30, 2025 | 820,000.00 |
| Mar 31, 2025 | 819,000.00 |
| Mar 31, 2025 | 819,000.00 |
| Dec 31, 2024 | 935,000.00 |
| Dec 31, 2024 | 935,000.00 |
| Sep 30, 2024 | 901,000.00 |
| Sep 30, 2024 | 901,000.00 |
| Jun 30, 2024 | 759,000.00 |
| Jun 30, 2024 | 759,000.00 |
| Mar 31, 2024 | 705,000.00 |
| Mar 31, 2024 | 705,000.00 |
| Dec 31, 2023 | 533,000.00 |
| Dec 31, 2023 | 533,000.00 |